These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17638891)

  • 1. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
    Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
    Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
    Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
    Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
    Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
    Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
    Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
    Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
    Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
    Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
    Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
    Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
    Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: a bioassay to identify primary human prostate cancer repopulating cells.
    Toivanen R; Berman DM; Wang H; Pedersen J; Frydenberg M; Meeker AK; Ellem SJ; Risbridger GP; Taylor RA
    Stem Cells; 2011 Aug; 29(8):1310-4. PubMed ID: 21674698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for cancer stem cells in human endometrial carcinoma.
    Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
    Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of cancer stem cells in human prostate cancer cells.
    Lee EK; Cho H; Kim CW
    Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a subpopulation of colon cancer cells with stem cell-like properties.
    Chu P; Clanton DJ; Snipas TS; Lee J; Mitchell E; Nguyen ML; Hare E; Peach RJ
    Int J Cancer; 2009 Mar; 124(6):1312-21. PubMed ID: 19072981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent oncolytic activity of human enteroviruses against human prostate cancer.
    Berry LJ; Au GG; Barry RD; Shafren DR
    Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
    Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis.
    Santamaria-Martínez A; Barquinero J; Barbosa-Desongles A; Hurtado A; Pinós T; Seoane J; Poupon MF; Morote J; Reventós J; Munell F
    Exp Cell Res; 2009 Oct; 315(17):3004-13. PubMed ID: 19447103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
    Gao AC; Lou W; Sleeman JP; Isaacs JT
    Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.